Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
better yet, can someone show me a real PR about these 2 alleged approvals they got...? other than singapore yahoo
guess they hate the truth?
where's the newwwwwwwwwwwwwws....???
same with APCVZ
wonder how much CCTC paid him?
what else is new, that's why i steer clear of his crap....you know he's loaded and ready to dump
comforting to know the IR department is incompetent
translation....i will never play a shakerzzzz play
translation...shakezzzz is front loaded
i wouldn't call yahoo singapore news a major news source...i don't see it on my ticker anywhere, nor is it on regular Yahoo
no clue man...I am in another one like that ROHI, company never PRd an 88 Million dollar government contract, lucky I got in and held from .60s
likewise, otherwise, it just looks a little too fishy
when i see it on a legit news source or ticker, i'll believe it
where'd you find this tid bit of news..?
gotta love these guys who sit here all night and answer their own questions
ABK tanking PM on earnings ( if you wanna call it that)
CYTX sells 1st US StemSource Cell Bank !!!
May 18, 2010 07:30 AM Eastern Daylight Time
Cytori Sells First U.S. StemSource® Cell Bank
SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) has sold its first StemSource® Cell Bank in the United States. The StemSource® Cell Bank is a suite of products that offers patients a way to store their own adipose tissue, or the stem and regenerative cells naturally occurring within their own adipose tissue, in an automated, affordable and safe manner. This adipose tissue bank is expected to be installed during the next few months, making it the fourth StemSource® Cell Bank to be installed worldwide and the first in the United States.
A StemSource® Cell Bank sale includes a proprietary processing system and other related equipment, custom operating software, standard operating procedures and protocols (SOPs), installation and training. The StemSource® Cell Bank facilitates the preparation and storage of stem and regenerative cells from fat tissue using methods that have been optimized by Cytori, creating significant economic and process efficiencies.
About Cytori
Cytori is a leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the United States. Our StemSource® product line is sold globally for cell banking and research applications. www.cytori.com
Cautionary Statement Regarding Forward-Looking Statements
This communication includes forward-looking statements regarding events, trends and business prospects, which may affect our future operating results and financial position. Such statements are subject to risks and uncertainties that could cause our actual results and financial position to differ materially. Some of these risks include clinical and regulatory uncertainties, including risks in the collection and results of clinical data, final clinical outcomes, dependence on third party performance, and other risks and uncertainties described under the "Risk Factors" in Cytori's Securities and Exchange Commission Filings on Form 10-K and 10-Q. We assume no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made.
Contacts
Cytori Therapeutics
Tom Baker
858-875-5279
tbaker@cytori.com
COIN big gap up on earnings release AH last night
May 18, 2010 07:30 AM Eastern Daylight Time
Cytori Sells First U.S. StemSource® Cell Bank
SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) has sold its first StemSource® Cell Bank in the United States. The StemSource® Cell Bank is a suite of products that offers patients a way to store their own adipose tissue, or the stem and regenerative cells naturally occurring within their own adipose tissue, in an automated, affordable and safe manner. This adipose tissue bank is expected to be installed during the next few months, making it the fourth StemSource® Cell Bank to be installed worldwide and the first in the United States.
A StemSource® Cell Bank sale includes a proprietary processing system and other related equipment, custom operating software, standard operating procedures and protocols (SOPs), installation and training. The StemSource® Cell Bank facilitates the preparation and storage of stem and regenerative cells from fat tissue using methods that have been optimized by Cytori, creating significant economic and process efficiencies.
About Cytori
Cytori is a leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the United States. Our StemSource® product line is sold globally for cell banking and research applications. www.cytori.com
Cautionary Statement Regarding Forward-Looking Statements
This communication includes forward-looking statements regarding events, trends and business prospects, which may affect our future operating results and financial position. Such statements are subject to risks and uncertainties that could cause our actual results and financial position to differ materially. Some of these risks include clinical and regulatory uncertainties, including risks in the collection and results of clinical data, final clinical outcomes, dependence on third party performance, and other risks and uncertainties described under the "Risk Factors" in Cytori's Securities and Exchange Commission Filings on Form 10-K and 10-Q. We assume no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made.
Contacts
Cytori Therapeutics
Tom Baker
858-875-5279
tbaker@cytori.com
agreed, adultprodigy
ouch, bend over
just like that IHSN , on sale now for .0204 and allegedly being bought out for .40, SUCH A DEAL, ALREADY !
why not, he's pretty much always been here anyway
ok, thanks janice
what was his sentence, being able to come back here and live a normal life..?
EVO might be hiding out overseas from all the guys whose last name ends in a vowel...
what was Matts plea....?
not personal..just song lyrics
yep, so true doug....the shameless humpers got them some more baggies
believe it or not, i do more with my life than sit here and hump POS's
yep, and yet the shameless pumpers were still here this morning before the market opened, screaming of what a buy it was....truly despicable, imo
yeah, and the pumpers where here whoring it this morning too, when it was .26 PM.....shameless
and another one gone, and another one gone, another one bites the dust !
yeah, room to grow for certain
Get in now, while you can ????...doesn't look like there's a shortage of shares at .0002
RPRX 1/5 RS
AEZS strong FDA news pre open, look for 2.50+
what was/is Mattys plea?
does anyone really think EVO is among the living...?
dude, this is the penny market here, it has a mind of its own, it does not trade in unison with the dow or S&P...and this will continue to drop without a solid PR and as long as the paid promoters have a hold of it, imo
i say a close of .078